Despite closing in the green, the S&P 500's Healthcare Index declined by 1.8% last week, overshadowed by President Trump's introduction of significant tariffs on branded drugs. Centene and Molina Healthcare recorded notable gains, each increasing by nearly 10%, while other companies like Mettler-Toledo and Regeneron faced declines of approximately 5%. Berkshire Hathaway's $1.57 billion stock purchase indicates continued investor interest, even as major players like UnitedHealth and Molina contend with pressures from rising costs and shifting market dynamics.
“The S&P 500 · closed · in the green · on Friday”
“The S&P 500 Health Care Index Sector · declined · about 1.8% · during the week”
“Centene · increased · 9.68% · last week”
“Molina Healthcare · increased · 9.66% · last week”
“McKesson · increased · 8.89% · last week”
“Universal Health Services · increased · 6.46% · last week”
“Cencora · increased · 5.86% · last week”
“Mettler-Toledo International · decreased · 4.83% · last week”
“Regeneron Pharmaceuticals · decreased · 4.75% · last week”
“Baxter International · decreased · 4.52% · last week”
“Incyte · decreased · 4.43% · last week”
“Charles River Laboratories · decreased · 4.40% · last week”
